Inside MedSpa — Daily Brief, 2026-06-26
The few things that actually moved in medical aesthetics — distilled. The headlines are free. The so-what is for subscribers.
1FDA Approves Skinvive by Juvéderm for Neck Lines
What happenedAllergan Aesthetics received FDA approval for Skinvive by Juvéderm for improvement of neck appearance and lines. This is a new indication for the existing Juvéderm platform.
2FDA Approves Restylane Contour for Temple Hollowing
What happenedGalderma received FDA approval for Restylane Contour for correction of temple hollowing, a new indication for this filler product.
3FDA Approves RHA Dynamic Volume for Midface Augmentation
What happenedRHA Dynamic Volume received FDA approval for midface augmentation and age-related volume loss, expanding the indication for this filler line.
4GLP-1 Weight Loss Drugs Drive Demand for Facial Volume Restoration
What happenedIndustry leaders have confirmed that facial fat loss from GLP-1 weight loss drugs (such as semaglutide) is a real, documented side effect, creating a new patient population seeking correction.
This is one morning. Get it every morning.
The full brief — what each item means for your practice and exactly what to do about it — lands in your inbox daily. $20 a month. Never be the last to know.
Get the daily brief — $20/mo